Department | Overall | Cardiogeriatrics | Cardiology | p |
---|---|---|---|---|
N (%) | 308 | 66 (21.4) | 242 (78.6) | Â |
Age, yrs. | 75.8 ± 13.5 | 82.4 ± 9.2 | 74.0 ± 13.8 | < 0.001 |
Age classes, n(%) |  |  |  | < 0.001 |
  < 45 yrs. | 9 (2.9) | 0 (0) | 9 (3.7) |  |
 45–74 yrs. | 125 (40.6) | 12 (16.7) | 114 (47.1) |  |
 75–85 yrs. | 98 (31.8) | 26 (39.4) | 72 (29.7) |  |
  > 85 yrs. | 76 (24.6) | 28 (42.4) | 48 (19.8) |  |
Female Gender, n(%) | 133 (43.3) | 32 (49.2) | 101 (41.7) | Â |
Live alone, n(%) | 54 (17.5) | 24 (36.4) | 30 (12.4) | < 0.001 |
Married, n(%) | 70 (22.7) | 14 (21.2) | 56 (23.1) | 0.869 |
Live with family, n(%) | 31 (10.1) | 6 (9.1) | 25 (10.3) | 1 |
Live in institution, n(%) | 3 (1) | 3 (4.5) | 0 | 0.009 |
IDH | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.54 ± 0.1 | < 0.001 |
Coronary heart disease, n(%) | 115 (37.8) | 23 (35.4) | 92 (38.5) | 0.668 |
Amyloidosis, n(%) | 28 (9.2) | 1 (1.5) | 27 (11.2) | 0.014 |
Hypertension, n(%) | 207 (67.9) | 44 (67.7) | 163 (67.9) | 1 |
Diabetes, n(%) | 112 (36.7) | 17 (26.2) | 95 (39.6) | 0.059 |
Smoker, n(%) | 38 (12.5) | 8 (12.3) | 30 (12.5) | 1 |
Chronic alcohol intake, n(%) | 23 (7.5) | 5 (7.7) | 18 (7.5) | 1 |
Chronic kidney disease, n(%) | 141 (46.2) | 27 (41.5) | 114 (47.5) | 0.404 |
COPD, n(%) | 65 (21.3) | 14 (21.5) | 51 (21.2) | 1 |
History of heart failure, n(%) | 203 (66.8) | 43 (66.1) | 160 (66.9) | 1 |
Stroke, n(%) | 47 (15.4) | 13 (20) | 34 (14.2) | 0.25 |
Atrial fibrillation, n(%) | 181 (59.3) | 38 (58.5) | 143 (59.6) | 0.888 |
Dementia, n(%) | 24 (7.9) | 20 (13.6) | 11 (4.68) | < 0.001 |
Depression, n(%) | 15 (4.9) | 9 (13.6) | 6 (2.5) | 0.001 |
BMI, kg/m2 | 27.1 ± 7.2 | 26.2 ± 6.6 | 27.2 ± 7.3 | 0.03 |
SBP, mmHg | 122 ± 20 | 122 ± 18 | 123 ± 22 | 0.855 |
LVEF classes, n(%) | Â | Â | Â | 0.584 |
  > 50% | 69 (22.4) | 13 (19.7) | 56 (23.1) |  |
 40–50% | 53 (17.2) | 14 (21.2) | 39 (16.1) |  |
  < 40% | 186 (60.4) | 39 (59.19) | 147 (60.7) |  |
BNP at discharge, pg/ml | 554 ± 745 | 618 ± 823 | 300 ± 112 | 0.001 |
Length of stay, days | 12.7 ± 10.1 | 19.3 ± 15.4 | 11.2 ± 7.3 | < 0.001 |
Creatinemia at discharge, days | 134 ± 63 | 118 ± 38 | 137 ± 67 | 0.18 |
Prescription at discharge, n(%) | 292 (95.74) | 63 (95.45) | 229 (95.82) | 0.254 |
ACEi, n(%) | 133 (43.9) | 34 (53.1) | 99 (41.4) | 0.118 |
ACEisup50, n(%) | 53 (17.5) | 12 (18.7) | 41 (17.1) | 0.853 |
ARNi, n(%) | 25 (8.2) | 5 (7.8) | 20 (8.3) | 1 |
ARNisup50, n(%) | 13 (4.3) | 5 (7.8) | 8 (3.3) | 0.157 |
Diuretic, n(%) | 259 (85.2) | 51 (79.7) | 208 (86.7) | 0.169 |
Dose Diuretic, n(%) | 118 ± 190 | 71 ± 117 | 131 ± 204 | 0.002 |
Beta blocker, n(%) | 208 (68.4) | 46 (71.9) | 162 (67.5) | 0.548 |
Beta blockersup50, n(%) | 83 (27.3) | 14 (21.9) | 69 (28.7) | 0.344 |
MRA, n(%) | 61 (20.1) | 7 (10.9) | 54 (22.5) | 0.052 |
MRAsup50, n(%) | 45 (14.8) | 6 (9.4) | 39 (16.2) | 0.234 |
Ivabradine, n(%) | 7 (2.3) | 2 (3.1) | 5 (2.1) | 0.641 |
LCZ696, n(%) | 25 (8.2) | 5 (7.8) | 20 (8.3) | 1 |
Pacemaker, n(%) | 41 (13.4) | 16 (24.2) | 25 (10.4) | 0.007 |
ICD, n(%) | 43 (14.1) | 2 (3) | 41 (17.1) | 0.002 |
Well Treated, n(%) | 24 (7.9) | 36 (56.2) | 118 (49.2) | 0.328 |